The Search for Biomarkers in Endometriosis: a Long and Windy Road

. 2022 Jun ; 29 (6) : 1667-1673. [epub] 20210622

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid34159571
Odkazy

PubMed 34159571
DOI 10.1007/s43032-021-00668-2
PII: 10.1007/s43032-021-00668-2
Knihovny.cz E-zdroje

Endometriosis is a complex and chronic estrogen-dependent disease, affecting a significant proportion of women of reproductive age. Despite the long interest and extensive research, the pathogenesis of the disease is still debated. Although available non-invasive diagnostic methods have adequate accuracy, an invasive approach by laparoscopy is often necessary to obtain histological confirmation. In this scenario, the search for an accurate, reliable, cost-effective, clinically applicable non-invasive biomarker plays a crucial role in a potentially early diagnosis and, in this way, shape the future management of the disease. Considering these elements, the current review aims to summarize the most significant and novel results about biomarkers for the diagnosis and follow-up of women affected by endometriosis.

Zobrazit více v PubMed

Missmer SA, Cramer DW. The epidemiology of endometriosis. Obstet Gynecol Clin N Am. 2003;30:1–19 vii. DOI

Baldi A, Campioni M, Signorile PG. Endometriosis: pathogenesis, diagnosis, therapy and association with cancer (review). Oncol Rep. 2008;19:843–6. PubMed

Laganà AS, Garzon S, Götte M, Viganò P, Franchi M, Ghezzi F, et al. The pathogenesis of endometriosis: molecular and cell biology insights. Int J Mol Sci. 2019;20(22):5615. DOI PMC

Sundqvist J, Andersson KL, Scarselli G, Gemzell-Danielsson K, Lalitkumar PG. Expression of adhesion, attachment and invasion markers in eutopic and ectopic endometrium: a link to the aetiology of endometriosis. Hum Reprod. 2012;27(9):2737–46. PubMed DOI

Garzon S, Laganà AS, Barra F, Casarin J, Cromi A, Raffaelli R, et al. Aromatase inhibitors for the treatment of endometriosis: a systematic review about efficacy, safety and early clinical development. Expert Opin Investig Drugs. 2020;29:1377–88. PubMed DOI

Riemma G, Laganà AS, Schiattarella A, Garzon S, Cobellis L, Autiero R, et al. Ion channels in the pathogenesis of endometriosis: a cutting-edge point of view. Int J Mol Sci. 2020;21(3):1114. DOI PMC

Della Corte L, Noventa M, Ciebiera M, Magliarditi M, Sleiman Z, Karaman E, et al. Phytotherapy in endometriosis: an up-to-date review. J Complement Integr Med. 2020;17(3):/j/jcim.2020.17.issue-3/jcim-2019-0084/jcim-2019-0084.xml. DOI

Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382:1244–56. PubMed DOI

Garzon S, Laganà AS, Barra F, Casarin J, Cromi A, Raffaelli R, et al. Novel drug delivery methods for improving efficacy of endometriosis treatments. Expert Opin Drug Deliv. 2020;27:1–13. https://doi.org/10.1080/17425247.2021.1829589 . DOI

Ghai V, Jan H, Shakir F, Haines P, Kent A. Diagnostic delay for superficial and deep endometriosis in the United Kingdom. J Obstet Gynaecol. 2020;40(1):83–9. PubMed DOI

Anastasiu CV, Moga MA, Elena Neculau A, Bălan A, Scârneciu I, Dragomir RM, et al. Biomarkers for the noninvasive diagnosis of endometriosis: state of the art and future perspectives. Int J Mol Sci. 2020;21(5):1750. DOI PMC

Králíčková M, Vetvicka V. Endometriosis and ovarian cancer. World J Clin Oncol. 2014;5:800–5. PubMed DOI PMC

Hudson QJ, Ashjaei K, Perricos A, Kuessel L, Husslein H, Wenzl R, et al. Endometriosis patients show an increased M2 response in the peritoneal CD14+low/CD68+low macrophage subpopulation coupled with an increase in the T-helper 2 and T-regulatory cells. Reprod Sci. 2020;27:1920–31. PubMed DOI

Ottolina J, Bartiromo L, Dolci C, Salmeri N, Schimberni M, Villanacci R, et al. Assessment of coagulation parameters in women affected by endometriosis: validation study and systematic review of the literature. Diagnostics (Basel). 2020;10:567. DOI

Berbic M, Fraser IS. Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J Reprod Immunol. 2011;88:149–55. PubMed DOI

Osuga Y, Koga K, Hirota Y, Hirata T, Yoshino O, Taketani Y. Lymphocytes in endometriosis. Am J Reprod Immunol. 2011;65:1–10. PubMed DOI

Gueuvoghlanian-Silva BY, Hernandes C, Correia RP, Podgaec S. Deep infiltrating endometriosis and activation and memory surface markers and cytokine expression in isolated Treg cells. Reprod Sci. 2020;27:599–610. PubMed DOI

Meng Q, Sun W, Jiang J, Fletcher NM, Diamond MP, Saed GM. Identification of common mechanisms between endometriosis and ovarian cancer. J Assist Reprod Genet. 2011;28:917–23. PubMed DOI PMC

Ponandai-Srinivasan S, Saare M, Boggavarapu NR, Frisendahl C, Ehrström S, Riethmüller C, et al. Syndecan-1 modulates the invasive potential of endometrioma via TGF-β signalling in a subgroup of women with endometriosis. Hum Reprod. 2020;35:2280–93. PubMed DOI

Karamian A, Paktinat S, Esfandyari S, Nazarian H, Ali Ziai S, Zarnani AH, et al. Pyrvinium pamoate induces in-vitro suppression of IL-6 and IL-8 produced by human endometriotic stromal cells. Hum Exp Toxicol. 2021;40:649–60. PubMed DOI

Gica N, Panaitescu AM, Iancu G, Botezatu R, Peltecu G, Gica C. The role of biological markers in predicting infertility associated with non-obstructive endometriosis. Ginekol Pol. 2020;91:189–92. PubMed DOI

Shimizu K, Kamada Y, Sakamoto A, Matsuda M, Nakatsuka M, Hiramatsu Y. High expression of high-mobility group box 1 in menstrual blood: implications for endometriosis. Reprod Sci. 2017;24:1532–7. PubMed DOI

Santulli P, Borghese B, Chouzenoux S, Vaiman D, Borderie D, Streuli I, et al. Serum and peritoneal interleukin-33 levels are elevated in deeply infiltrating endometriosis. Hum Reprod. 2012;27:2001–9. PubMed DOI

Miller JE, Monsanto SP, Ahn SH, Khalaj K, Fazleabas AT, Young SL, et al. Interleukin-33 modulates inflammation in endometriosis. Sci Rep. 2017;7:17903. PubMed DOI PMC

Dorien O, Waelkens E, Vanhie A, Peterse D, Fassbender A, D’Hooghe T. The use of antibody arrays in the discovery of new plasma biomarkers for endometriosis. Reprod Sci. 2020;27:751–62. DOI

Guo M, Bafligil C, Tapmeier T, Hubbard C, Manek S, Shang C, et al. Mass cytometry analysis reveals a distinct immune environment in peritoneal fluid in endometriosis: a characterisation study. BMC Med. 2020;18:3. PubMed DOI PMC

Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M, et al. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res. 2013;19:1213–24. PubMed DOI PMC

Siufi Neto J, Kho RM, Siufi DF, Baracat EC, Anderson KS, Abrão MS. Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer. J Minim Invasive Gynecol. 2014;21:55–63. PubMed DOI

Papari E, Noruzinia M, Kashani L, Foster WG. Identification of candidate microRNA markers of endometriosis with the use of next-generation sequencing and quantitative real-time polymerase chain reaction. Fertil Steril. 2020;113:1232–41. PubMed DOI

Gao S, Liu S, Gao ZM, Deng P, Wang DB. Reduced microRNA-451 expression in eutopic endometrium contributes to the pathogenesis of endometriosis. World J Clin Cases. 2019;7:2155–64. PubMed DOI PMC

Chen S, Luo Y, Cui L, Yang Q. miR-96-5p regulated TGF-β/SMAD signaling pathway and suppressed endometrial cell viability and migration via targeting TGFBR1. Cell Cycle. 2020;19:1740–53. PubMed DOI PMC

Vanhie A, O D, Peterse D, Beckers A, Cuéllar A, Fassbender A, et al. Plasma miRNAs as biomarkers for endometriosis. Hum Reprod. 2019;34:1650–60. PubMed DOI PMC

Madjid TH, Ardiansyah DF, Permadi W, Hernowo B. Expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in endometriosis menstrual blood. Diagnostics (Basel). 2020;10(6):364. DOI

Bostanci Durmus A, Dincer Cengiz S, Yılmaz H, Candar T, Gursoy AY, Sinem CG. The levels of matrix metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in different stages of endometriosis. J Obstet Gynaecol. 2019;39:991–5. PubMed DOI

Weigel MT, Krämer J, Schem C, Wenners A, Alkatout I, Jonat W, et al. Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol. 2012;160:74–8. PubMed DOI

Liu C, Chen Y, Chen M, Mao X, Dong B, Sun P. A novel non-invasive molecular biomarker in ovarian endometriosis: estrogen-related receptor α. Arch Gynecol Obstet. 2020;302:405–14. PubMed DOI

Proestling K, Wenzl R, Yotova I, Hauser C, Husslein H, Kuessel L. Investigating selected adhesion molecules as urinary biomarkers for diagnosing endometriosis. Reprod BioMed Online. 2020;40:555–8. PubMed DOI

Kocbek V, Vouk K, Mueller MD, Rižner TL, Bersinger NA. Elevated glycodelin-A concentrations in serum and peritoneal fluid of women with ovarian endometriosis. Gynecol Endocrinol. 2013;29:455–9. PubMed DOI

Drosdzol-Cop A, Skrzypulec-Plinta V. Selected cytokines and glycodelin A levels in serum and peritoneal fluid in girls with endometriosis. J Obstet Gynaecol Res. 2012;38:1245–53. PubMed DOI

Li Y, Chen Q. Circulating non-coding RNAs as non-invasive diagnostic markers of endometriosis: a comprehensive meta-analysis. Arch Gynecol Obstet. 2019;300:1099–112. PubMed DOI

Joseph S, Mahale SD. Endometriosis knowledgebase: a gene-based resource on endometriosis. Database (Oxford). 2019;2019:baz062. DOI

Ortiz-Muñoz B, Aznar-Oroval E, García García A, Covisa Peris A, Perez Ballestero P, Sanchez Yepes M, et al. HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer. Tumour Biol. 2014;35:7249–58. PubMed DOI

Jacob F, Meier M, Caduff R, Goldstein D, Pochechueva T, Hacker N, et al. No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. Gynecol Oncol. 2011;121:487–91. PubMed DOI

Huhtinen K, Suvitie P, Hiissa J, Junnila J, Huvila J, Kujari H, et al. Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer. 2009;100:1315–9. PubMed DOI PMC

Zapardiel I, Gorostidi M, Ravaggi A, Allende MT, Silveira M, Abehsera D, et al. Utility serum marker HE4 for the differential diagnosis between endometriosis and adnexal malignancy. Int J Gynecol Cancer. 2016;26:52–5. PubMed DOI

Bandiera E, Zanotti L, Fabricio AS, Bucca E, Squarcina E, Romani C, et al. Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. Clin Chem Lab Med. 2013;51:1815–24. PubMed DOI

Bast RC Jr, Xu FJ, Yu YH, Barnhill S, Zhang Z, Mills GB. CA 125: the past and the future. Int J Biol Markers. 1998;13:179–87. PubMed DOI

Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68(5):1331–7. PubMed DOI PMC

Králíčková M, Losan P, Vetvicka V. Endometriosis and cancer. Womens Health (Lond). 2014;10:591–7. DOI

Pittaway DE, Fayez JA. The use of CA-125 in the diagnosis and management of endometriosis. Fertil Steril. 1986;46:790–5. PubMed DOI

Toki T, Kubota J, Lu X, Nakayama K. Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation. Acta Obstet Gynecol Scand. 2000;79:771–6. PubMed

Sütcü HK, Celik GIT, Akpak YK, Akar ME, Taşkın Ö, Ozdem S, et al. The value of CA-125, CA 19-9, Interleukin-6, Interleukin-8 and hsCRP in the diagnosis of endometriosis. Acta Medica Mediterranea. 2015;31:793–9.

Shinmura H, Yoneyama K, Harigane E, Tsunoda Y, Fukami T, Matsushima T, et al. Use of tumor markers to distinguish endometriosis-related ovarian neoplasms from ovarian endometrioma. Int J Gynecol Cancer. 2020;30:831–6. PubMed DOI PMC

Li M, Tan J, Zhang Y, Ai C, Wang H, Zhang H, et al. Assessing CT imaging features combined with CEA and CA125 levels to identify endometriosis-associated ovarian cancer. Abdom Radiol (NY). 2020;46:2367–75. https://doi.org/10.1007/s00261-020-02571-x . DOI

Jing X, Li C, Sun J, Peng J, Dou Y, Xu X, et al. Systemic inflammatory response markers associated with infertility and endometrioma or uterine leiomyoma in endometriosis. Ther Clin Risk Manag. 2020;16:403–12. PubMed DOI PMC

Ding S, Lin Q, Zhu T, Li T, Zhu L, Wang J, et al. Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis? BMC Womens Health. 2019;19:169. PubMed DOI PMC

Liu S, Zhou J, Wen J. Expression and significance of CD133 and ABCG2 in endometriosis. Clin Exp Obstet Gynecol. 2015;42:771–5. PubMed DOI

Tempest N, Maclean A, Hapangama DK. Endometrial stem cell markers: current concepts and unresolved questions. Int J Mol Sci. 2018;19(10):3240. DOI PMC

Kao AP, Wang KH, Chang CC, Lee JN, Long CY, Chen HS, et al. Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model. Fertil Steril. 2011;95:1308–15.e1. PubMed DOI

Chan RW, Ng EH, Yeung WS. Identification of cells with colony-forming activity, self-renewal capacity, and multipotency in ovarian endometriosis. Am J Pathol. 2011;178:2832–44. PubMed DOI PMC

Liu Y, Liang S, Yang F, Sun Y, Niu L, Ren Y, et al. Biological characteristics of endometriotic mesenchymal stem cells isolated from ectopic lesions of patients with endometriosis. Stem Cell Res Ther. 2020;11:346. PubMed DOI PMC

Valentijn AJ, Palial K, Al-Lamee H, Tempest N, Drury J, Von Zglinicki T, et al. SSEA-1 isolates human endometrial basal glandular epithelial cells: phenotypic and functional characterization and implications in the pathogenesis of endometriosis. Hum Reprod. 2013;28:2695–708. PubMed DOI

Song Y, Xiao L, Fu J, Huang W, Wang Q, Zhang X, et al. Increased expression of the pluripotency markers sex-determining region Y-box 2 and Nanog homeobox in ovarian endometriosis. Reprod Biol Endocrinol. 2014;12:42. PubMed DOI PMC

Shariati F, Favaedi R, Ramazanali F, Ghoraeian P, Afsharian P, Aflatoonian B, et al. Increased expression of stemness genes REX-1, OCT-4, NANOG, and SOX-2 in women with ovarian endometriosis versus normal endometrium: a case-control study. Int J Reprod Biomed. 2019;16:ijrm.v16i12.3684. PubMed PMC

Chang JH, Au HK, Lee WC, Chi CC, Ling TY, Wang LM, et al. Expression of the pluripotent transcription factor OCT4 promotes cell migration in endometriosis. Fertil Steril. 2013;99:1332–1339.e5. PubMed DOI

Zhang Y, Eades G, Yao Y, Li Q, Zhou Q. Estrogen receptor α signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2. J Biol Chem. 2012;287(49):41514–22. PubMed DOI PMC

Yang L, Luo L, Ji W, Gong C, Wu D, Huang H, et al. Effect of low dose bisphenol A on the early differentiation of human embryonic stem cells into mammary epithelial cells. Toxicol Lett. 2013;218:187–93. PubMed DOI

Abramiuk M, Grywalska E, Korona-Glowniak I, Niedzwiedzka-Rystwej P, Polak G, Kotarski J, et al. CD200 and CD200R expression on peripheral blood lymphocytes and serum CD200 concentration as a new marker of endometriosis. J Clin Med. 2020;9. https://doi.org/10.3390/jmc9093035 .

Nothnick WB. MicroRNAs and endometriosis: distinguishing drivers from passengers in disease pathogenesis. Semin Reprod Med. 2017;35:173–80. PubMed DOI PMC

Li Y, Chen Q. Circulating non-coding RNA as non-invasive diagnostic markers of endometriosis: a comprehensive meta-analysis. Arch Gynecol Obstet. 2019;300:1099–112. PubMed DOI

Papari E, Noruzinia M, Kashani L, Foster WG. Identification of candidate microRNA markers of endometriosis with the use of next-generation sequencing and quantitative re3al-time polymerase chain reaction. Fertil Steril. 2020;113:1232–41. PubMed DOI

Liu C, Chen YJ, Chen M, Mao XD, Dong BH, Sun PM. A novel non-invasive molecular biomarker in ovarian endometriosis: estrogen-related receptor A. Arch Gynecol Obstet. 2020;302:405–14. PubMed DOI

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Endometriosis and gynaecological cancers: molecular insights behind a complex machinery

. 2021 Dec ; 20 (4) : 201-206. [epub] 20211206

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...